These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


240 related items for PubMed ID: 34364926

  • 1. Atypical antipsychotic drugs deregulate the cholesterol metabolism of macrophage-foam cells by activating NOX-ROS-PPARγ-CD36 signaling pathway.
    Chen CH, Leu SJ, Hsu CP, Pan CC, Shyue SK, Lee TS.
    Metabolism; 2021 Oct; 123():154847. PubMed ID: 34364926
    [Abstract] [Full Text] [Related]

  • 2. Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling.
    Zhou MS, Chadipiralla K, Mendez AJ, Jaimes EA, Silverstein RL, Webster K, Raij L.
    Am J Physiol Heart Circ Physiol; 2013 Aug 15; 305(4):H563-74. PubMed ID: 23748423
    [Abstract] [Full Text] [Related]

  • 3. ROS via BTK-p300-STAT1-PPARγ signaling activation mediates cholesterol crystals-induced CD36 expression and foam cell formation.
    Kotla S, Singh NK, Rao GN.
    Redox Biol; 2017 Apr 15; 11():350-364. PubMed ID: 28040583
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM.
    Yu M, Jiang M, Chen Y, Zhang S, Zhang W, Yang X, Li X, Li Y, Duan S, Han J, Duan Y.
    J Biol Chem; 2016 Aug 12; 291(33):16977-89. PubMed ID: 27358406
    [Abstract] [Full Text] [Related]

  • 5. Activation of Peroxisome Proliferator-activated Receptor γ (PPARγ) and CD36 Protein Expression: THE DUAL PATHOPHYSIOLOGICAL ROLES OF PROGESTERONE.
    Yang X, Zhang W, Chen Y, Li Y, Sun L, Liu Y, Liu M, Yu M, Li X, Han J, Duan Y.
    J Biol Chem; 2016 Jul 15; 291(29):15108-18. PubMed ID: 27226602
    [Abstract] [Full Text] [Related]

  • 6. The detrimental effect of asymmetric dimethylarginine on cholesterol efflux of macrophage foam cells: Role of the NOX/ROS signaling.
    Chen CH, Zhao JF, Hsu CP, Kou YR, Lu TM, Lee TS.
    Free Radic Biol Med; 2019 Nov 01; 143():354-365. PubMed ID: 31437479
    [Abstract] [Full Text] [Related]

  • 7. ROS-dependent Syk and Pyk2-mediated STAT1 activation is required for 15(S)-hydroxyeicosatetraenoic acid-induced CD36 expression and foam cell formation.
    Kotla S, Singh NK, Traylor JG, Orr AW, Rao GN.
    Free Radic Biol Med; 2014 Nov 01; 76():147-62. PubMed ID: 25152235
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. TREM2 promotes cholesterol uptake and foam cell formation in atherosclerosis.
    Guo X, Li B, Wen C, Zhang F, Xiang X, Nie L, Chen J, Mao L.
    Cell Mol Life Sci; 2023 May 03; 80(5):137. PubMed ID: 37133566
    [Abstract] [Full Text] [Related]

  • 10. ALDH2 deficiency inhibits Ox-LDL induced foam cell formation via suppressing CD36 expression.
    Wei S, Zhang L, Bailu Wang, Zhao Y, Dong Q, Pan C, Li C, He D, Yuan Q, Xu F, Chen Y.
    Biochem Biophys Res Commun; 2019 Apr 23; 512(1):41-48. PubMed ID: 30853183
    [Abstract] [Full Text] [Related]

  • 11. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway.
    Geng J, Yang C, Wang B, Zhang X, Hu T, Gu Y, Li J.
    Biomed Pharmacother; 2018 Jan 23; 97():941-947. PubMed ID: 29136772
    [Abstract] [Full Text] [Related]

  • 12. Crocin ameliorates atherosclerosis by promoting the reverse cholesterol transport and inhibiting the foam cell formation via regulating PPARγ/LXR-α.
    Zhang F, Liu P, He Z, Zhang L, He X, Liu F, Qi J.
    Cell Cycle; 2022 Jan 23; 21(2):202-218. PubMed ID: 34978526
    [Abstract] [Full Text] [Related]

  • 13. Amentoflavone prevents ox-LDL-induced lipid accumulation by suppressing the PPARγ/CD36 signal pathway.
    Zhuang JL, Liu YY, Li ZZ, Zhuang QZ, Tang WZ, Xiong Y, Huang XZ.
    Toxicol Appl Pharmacol; 2021 Nov 15; 431():115733. PubMed ID: 34599948
    [Abstract] [Full Text] [Related]

  • 14. WISP1 alleviates lipid deposition in macrophages via the PPARγ/CD36 pathway in the plaque formation of atherosclerosis.
    Liu D, Wang X, Zhang M, Tian J, Liu M, Jin T, Pan J, Gao M, An F.
    J Cell Mol Med; 2020 Oct 15; 24(20):11729-11741. PubMed ID: 32851768
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protein Kinase Cθ Via Activating Transcription Factor 2-Mediated CD36 Expression and Foam Cell Formation of Ly6Chi Cells Contributes to Atherosclerosis.
    Raghavan S, Singh NK, Gali S, Mani AM, Rao GN.
    Circulation; 2018 Nov 20; 138(21):2395-2412. PubMed ID: 29991487
    [Abstract] [Full Text] [Related]

  • 18. CML/CD36 accelerates atherosclerotic progression via inhibiting foam cell migration.
    Xu S, Li L, Yan J, Ye F, Shao C, Sun Z, Bao Z, Dai Z, Zhu J, Jing L, Wang Z.
    Biomed Pharmacother; 2018 Jan 20; 97():1020-1031. PubMed ID: 29136780
    [Abstract] [Full Text] [Related]

  • 19. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
    Dai XY, Cai Y, Sun W, Ding Y, Wang W, Kong W, Tang C, Zhu Y, Xu MJ, Wang X.
    Cardiovasc Res; 2014 Feb 01; 101(2):297-305. PubMed ID: 24253523
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.